Literature DB >> 22203424

Interaction of flucloxacillin and quinidine.

W J Comuth, J A Comuth, R N W Hauer, M M Malingré.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22203424     DOI： 10.1007/s00228-011-1179-0

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  3 in total

Review 1.  The contribution of P-glycoprotein to pharmacokinetic drug-drug interactions.

Authors:  D K Yu
Journal:  J Clin Pharmacol       Date:  1999-12       Impact factor: 3.126

2.  Rapid induction of P-glycoprotein expression by high permeability compounds in colonic cells in vitro: a possible source of transporter mediated drug interactions?

Authors:  Andrew Collett; Jolanta Tanianis-Hughes; Geoff Warhurst
Journal:  Biochem Pharmacol       Date:  2004-08-15       Impact factor: 5.858

3.  Induction of cytochrome P450 3A4 and P-glycoprotein by the isoxazolyl-penicillin antibiotic flucloxacillin.

Authors:  Jörg Huwyler; Matthew B Wright; Heike Gutmann; Juergen Drewe
Journal:  Curr Drug Metab       Date:  2006-02       Impact factor: 3.731
  3 in total
  4 in total

Review 1.  Ways to Improve Insights into Clindamycin Pharmacology and Pharmacokinetics Tailored to Practice.

Authors:  Laura Armengol Álvarez; Greet Van de Sijpe; Stefanie Desmet; Willem-Jan Metsemakers; Isabel Spriet; Karel Allegaert; Jef Rozenski
Journal:  Antibiotics (Basel)       Date:  2022-05-21

2.  Dicloxacillin induces CYP2C19, CYP2C9 and CYP3A4 in vivo and in vitro.

Authors:  Tore Bjerregaard Stage; Magnus Graff; Susan Wong; Louise Ladebo Rasmussen; Flemming Nielsen; Anton Pottegård; Kim Brøsen; Deanna L Kroetz; S Cyrus Khojasteh; Per Damkier
Journal:  Br J Clin Pharmacol       Date:  2018-01-10       Impact factor: 4.335

3.  Flucloxacillin decreases tacrolimus blood trough levels: a single-center retrospective cohort study.

Authors:  Herman Veenhof; Hugo M Schouw; Martine T P Besouw; Daan J Touw; Valentina Gracchi
Journal:  Eur J Clin Pharmacol       Date:  2020-07-25       Impact factor: 2.953

4.  Characterization of kinetics of human cytochrome P450s involved in bioactivation of flucloxacillin: inhibition of CYP3A-catalysed hydroxylation by sulfaphenazole.

Authors:  Stefan J Dekker; Floor Dohmen; Nico P E Vermeulen; Jan N M Commandeur
Journal:  Br J Pharmacol       Date:  2018-12-26       Impact factor: 8.739
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.